Dr. Eleanor M. Walker

Claim this profile

Henry Ford Hospital

Studies Cancer
Studies Prostate Adenocarcinoma
18 reported clinical trials
58 drugs studied

Area of expertise

1Cancer
Eleanor M. Walker has run 7 trials for Cancer. Some of their research focus areas include:
p16 negative
p16 positive
Stage IV
2Prostate Adenocarcinoma
Eleanor M. Walker has run 5 trials for Prostate Adenocarcinoma.

Affiliated Hospitals

Image of trial facility.
Henry Ford Hospital
Image of trial facility.
Henry Ford Macomb Hospital-Clinton Township

Clinical Trials Eleanor M. Walker is currently running

Image of trial facility.

High-Dose vs Low-Dose Cisplatin with Radiation

for Head and Neck Cancer

This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria

More about Eleanor M. Walker

Clinical Trial Related2 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 10 Active Clinical Trials
Treatments Eleanor M. Walker has experience with
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Radiation Therapy
  • Docetaxel
  • Flutamide
  • Fluorouracil

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eleanor M. Walker specialize in?
Eleanor M. Walker focuses on Cancer and Prostate Adenocarcinoma. In particular, much of their work with Cancer has involved p16 negative patients, or patients who are p16 positive.
Is Eleanor M. Walker currently recruiting for clinical trials?
Yes, Eleanor M. Walker is currently recruiting for 10 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Eleanor M. Walker has studied deeply?
Yes, Eleanor M. Walker has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Radiation Therapy.
What is the best way to schedule an appointment with Eleanor M. Walker?
Apply for one of the trials that Eleanor M. Walker is conducting.
What is the office address of Eleanor M. Walker?
The office of Eleanor M. Walker is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.